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ABSTRACT
Objective To identify interventions being used to manage 
attention- deficit/hyperactivity disorder (ADHD) in the UK.
Design A survey within the Sheffield Treatments for ADHD 
Research project. A convenience sample of participants in 
the UK who consented to join an observational cohort were 
asked closed questions about medication, behavioural 
change programmes and service use, and an open- ended 
question about what else they used.
Setting A broad variety of non- National Health Service, 
non- treatment seeking settings throughout the UK, 
including local authority organisations, schools, ADHD 
and autism spectrum condition support groups and social 
media.
Participants Families of children aged 5–18 with carer 
reported ADHD and Conners Global Index (CGI) T scores of 
55+.
Results Responses from 175 families were analysed. 
The mean age of the children was 10.21 (2.44), and two- 
thirds (n=114) had additional diagnoses. The majority 
used medications to manage ADHD (n=120) and had 
participated in a parenting class (n=130). Just over a 
quarter (28%, n=49) did not use ADHD medications, and 
used sleep medications. Just under half had consulted 
psychologists (n=83), and 32 had participated in other 
talking therapies such as psychotherapy, counselling and 
cognitive–behavioural therapy. A few used aids such as 
reward charts or fiddle toys (n=17) and participated in 
activities (mostly physical) (n=14). A substantial minority 
(78/175) had used non- mainstream treatments, the 
most popular being homoeopathy (n=32), nutritional 
interventions (n=21) and bodywork such as massage or 
cranial osteopathy (n=9).
Conclusions Families reported use of a wide variety of 
treatments to help with management of their children with 
ADHD in addition to their use of mainstream treatments.
INTRODUCTION
Attention- deficit/hyperactivity disorder 
(ADHD) is one of the most commonly diag-
nosed and treated childhood psychiatric 
disorders. Children are hyperactive (fidgety 
and unable to sit still for long periods), and 
impulsive (doing things without stopping 
to think). They find it hard to concentrate 
and follow instructions, and to regulate 
their emotions. This results in problems at 
school, at home, and with their peers where 
they struggle to fit in,1 and get into trouble.2 
Heterogeneity (non- uniformity) is a feature 
of ADHD expression. Children often have a 
wide range of other diagnoses and co- occur-
ring problems such as autism spectrum condi-
tions (ASCs) (50%–75%),3 conduct disor-
ders (24%),4 sleep disorders (25%–50%),5 
tics (60%),6 gut dysbiosis,7 obesity (40%),8 
anxiety, depression (33%),9 reading and 
other learning problems.10
Treating ADHD is challenging. Interven-
tions are offered to help manage symptoms. 
The National Health Service (NHS) offers 
National Institute for Health and Care Excel-
lence (NICE) recommended treatments of 
behaviour change programmes and pharma-
ceutical medications. Recent NICE updates 
suggest also asking about diet and offering 
advice if relevant. While implemented, recom-
mended treatments often palliate some symp-
toms making classroom and family life more 
What is known about the subject?
 ► For many of those with attention- deficit/hyperactivi-
ty disorder (ADHD) mainstream interventions do not 
improve long- term outcomes.
 ► Carers additionally try non- mainstream interven-
tions to help their children.
 ► Surveys documenting what carers try have been 
conducted in a variety of countries but not in the UK.
What this study adds?
 ► Families with children with ADHD in the UK are using 
a wide variety of main and non- mainstream treat-
ments, which are both publicly and privately funded, 
to help with ADHD management.
 ► Nearly 70% of those surveyed reported using phar-
maceutical medications, 74% had participated in 
a parenting class, and 45% reported use of non- 
mainstream treatments.
 ► The most popular non- mainstream treatments used 
were nutrition, homoeopathy, massage and cranial 
osteopathy.
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manageable, however, their long- term effectiveness and 
ability to address important negative outcomes remains 
in doubt.11 Adherence is poor and side effects of pharma-
ceutical medications common.12
While the majority of carers of children with ADHD 
in the UK rely on NICE recommended treatments, 
a number try other treatments, identified by them-
selves rather than doctor recommendation, and usually 
requiring out of pocket payments. Such treatments are 
collectively described in a variety of ways, and their cate-
gorisation also varies.
For the purposes of this article such treatments will 
be referred to as ‘non- mainstream’. Other descriptive 
terms for non- mainstream are ‘complementary and/
or complementary medicine’ referring to a broad set 
of healthcare practices that are not part of that coun-
try’s own tradition or conventional medicine and not 
fully integrated into the dominant healthcare system.13 
The term ‘integrative’ is used when conventional and 
complementary approaches are used in a coordinated 
way (https:// nccih. nih. gov). Treatments move from 
non- mainstream to mainstream as their evidence base 
and/or acceptability grows.
Non- mainstream treatments are also described 
as ‘natural’.14 Although doctors can be uncomfort-
able recommending treatments about which they are 
unknowledgeable and untrained,15 there is a growing 
interest in using natural medicines particularly in paedi-
atrics.16 17
Carer use of non- mainstream treatments for ADHD has 
been found to be driven by a desire for alternatives to 
pharmaceutical medications,17–19; to minimise symptoms 
of ADHD; for additional benefit combined with conven-
tional treatment; to avoid prescribed medication side 
effects,20 21 and dissatisfaction with conventional care.22 
Ninety per cent+ carers of children with ADHD surveyed 
hope to see more research on non- mainstream treat-
ments conducted.23
Surveys in several countries have sought to identify 
which and how frequently non- mainstream treatments 
are used to manage ADHD. Using Google Scholar, Web 
of Science and cross- referencing, 10 such surveys were 
found: three in Australia, five in the USA, one in Canada 
and one in Israel (table 1). No surveys were identified in 
the UK. This survey seeks to address this gap. Data about 
resource use was collected from a convenience sample of 
families recruited to the Sheffield Treatments for ADHD 
Research (STAR) project. The project used Trials within 
Cohorts (TwiCs) methodology,24 whereby first a large 
observational cohort of participants with the condition 
of interest was recruited and their outcomes of interest 
regularly measured.
This report describes the resource use reported by 
cohort participants at entry into the observational cohort 
(online supplemental appendix 1).25 Results of the pilot 
randomised controlled trials (RCTs) conducted within 
the cohort and detailed population characteristics are 
reported elsewhere.26
Patient and public involvement
The STAR project was preceded by a case series.27 Families 
with children with ADHD participating in this preceding 
study expressed frustration at the lack of helpful treat-
ment options and a desire to support research testing 
new treatments which might help their children. These 
families contributed to the design of the STAR project 
including: the design and piloting of the study question-
naire where an extra open- ended question ‘use this space 
for anything else you would like to tell us’ was added (see 
online supplemental appendix 1); and the generation 
of an interactive hip- hop rap performance called Lost 
Voices based on participating family’s stories, which was 




To describe what families in the UK are using to manage 
their children with ADHD.
Approvals
The STAR project (including the survey) was sponsored 
by the University of Sheffield (URMS number 143647), 
and approved under the University of Sheffield’s Ethics 
Review Procedure by the School of Health and Related 
Research (ScHARR) Research Ethics committee (REC) 
on 30/4/15, application number 00342425 Informed 
consent was received from all carers and children.
Study design
This survey reports the responses from UK families with 
children with ADHD who agreed to participate in an 
observational cohort.25 26
Recruitment
Families of children aged 5–18 with ADHD were recruited 
from a broad variety of non- NHS, non- treatment seeking 
settings, initially in Sheffield and then throughout the 
UK, between September 2015 and September 2016. 
These included local authority organisations, schools, 
ADHD and autism support groups, conferences, and 
social media.
Recruitment was via a questionnaire which could 
be completed on- line or on paper by carers and took 
approximately 10 min to complete (online supple-
mental appendix 1). Carers were asked to provide the 
date, address and name of the doctor who diagnosed 
the child’s ADHD and complete the Conners Global 
ADHD Index (CGI).29 To be included in the cohort chil-
dren were required to have a CGI T score of at least 55 
(denoting mild a- typicality). No restriction was placed on 
length of time since diagnosis.
Carers were asked questions intended to capture all 
treatments ever received by the child, not specifically for 
their ADHD: ‘ Please tell us about all your child’s diag-
noses and any medications taken for them’; ‘how often 
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have you visited/been visited by the doctor, hospital, 
social worker or police in the last 6 months’; ‘what else 
have you used to help your child in the past/now?: Family 
Action Parenting class (asked about on specific request 
from Sheffield Family Action); another parenting class? 
sessions with a psychologist?’; homoeopathy?’; (asked 
about due to inclusion/exclusion criteria for a subse-
quent RCT); anything else?’. This open- ended ‘anything 
else’ question was included to help identify all non- 
mainstream treatments that were or had been used. The 
final open- ended question ‘use this space for anything 




Questionnaires were completed by the carers of 194 chil-
dren. Nineteen of these children had no reported diag-
nosis of ADHD, so their responses were excluded, there-
fore, the total number of children included in the survey 
was 175.
Approximately one- third (35%) reported a sole diag-
nosis of ADHD, while the remaining two- thirds (65%) 
reported one or more additional diagnoses of which the 
most common was an ASC (table 2).
The mean age of the children was 10.21 (2.44). Eighty- 
four per cent were boys and sixteen per cent girls. During 
the previous 6 months, 12 children had been involved 
with the police (range 1–20 visits per child). Fifteen chil-
dren were involved with social workers (range 1–15 visits). 
Over half (n=104) had visited hospital (range 1–20 visits) 
and had visited doctors (n=117) (range 1–20 visits). Over 
half (56%) of children had a teaching assistant, of whom 
22% had one full time.
Resource use
Nearly two- thirds of the children were taking a main-
stream ADHD medication, of which most took a 
methylphenidate derivative such as Ritalin. Nearly one- 
third took sleep medications (table 3).
One- third of families had participated in behaviour 
focused therapies (range 1–5 therapies per family) 
(table 4). The most frequently reported was consultation 
with a psychologist. Just under three quarters had partic-
ipated in or were currently participating in parenting 
classes. Family Action is offered to all newly diagnosed 
families in Sheffield. Other classes mentioned were: 123 
magic, triple P, positive parenting, teach, change 4 life, 
anger management and incredible years.
Carers also described a wide variety of other creative 
and talking therapies that they used to help modify or 
manage behaviour. For example, art therapy, which was 
being offered by Sheffield Child and Adult Mental Health 
Services at the time.
A broad variety of activities ranging from the more 
physical such as judo, to the more creative such as theatre 
school, were described (range 1–4 activities per child). 
Seventeen families reported using aids, were which were 
usually to help the child with an accompanying ASC diag-
nosis (ear defenders and weighted blankets); or if hyper-
activity and lack of focus were the issue (fiddle toys and 
wobble cushions) (table 4).
Non-mainstream resource use
Nearly half (45%, n=78) reported non- mainstream resource 
use (range 1–5 per family), of which the most commonly 
reported was homoeopathy. The next most commonly 
reported was a dietary intervention: either taking an over 
the counter nutritional supplement, or diet changes, mostly 
without the support of a nutritional specialist (table 5).
There were responses from 61 participants to the open- 
ended question ‘use this space for anything else you would 
like to tell us’. Their free text comments were thematically 
analysed. Six categories emerged: friendships, school, 
home, family circumstances, medication and sleep.
Carers described how lack of friendships were an issue for 
their children: ‘My child gets excluded from parties, invi-
tations to friend’s houses and parents actively try to keep 
their children away’. School was problematic for both chil-
dren and their carers trying to help them: ‘today he didn't 
get up until I physically made him, he then missed his bus 
to school and then had an argument with other students 





  Sole diagnosis of ADHD 61
Additional Autism spectrum condition 54
Anxiety 14




A sensory processing disorder 11
Oppositional defiant disorder 8
Tourette’s syndrome 7
ADHD, attention- deficit/hyperactivity disorder.




















ADHD, attention- deficit/hyperactivity disorder.
6 Fibert P, Relton C. BMJ Paediatrics Open 2020;4:e000771. doi:10.1136/bmjpo-2020-000771
Open access
during lunch break. When finally I got him organised to sit 
down and do some homework it turned out he'd lost it on 
the way home. Quite a typical day!’.
Home life was described as stressful, particularly in the 
mornings: ‘Home life very much affected by X to the point 
of being ruled by her behaviour…. still not dressed today 
Table 4 Other resource use by families
Category Total no (n), (%) Question type Name (no using)
Parenting class 130 (74) Specific Family action parenting class (55)
Another parenting class (75)
Behaviour- focused therapy 115 (66) Specific Psychologist (83)









Aids (physical/visual/audial/behavioural) 17 (9) Open Reward charts (7)
Fiddle toys, wobble cushions (3)
Quiet tent/time out space/ear defenders (3)
Relaxation CDs/baths (2)
Weighted blankets (2)
Activities 14 (8) Open Horse riding (2)
Swimming (2)
Cycling (1)






Tae kwon do (1)
Theatre school (1)
Trampoline (1)
Table 5 Non- mainstream treatments used by families
Category Total no used Question type Name (number using)
Nutritional 21 Open Fish oils (9)
Dietary changes (restricting foods/Feingold diet/healthy diet) (7)
Dietician/nutritionist/nutritional therapy (3)
Other supplements (2)
Bodywork 9 Open Massage (5)
Cranial osteopathy (4)
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at 5pm despite numerous prompts’. Family circumstances 
described were specific traumas and bereavements: ‘ X was 
removed from birth mum at birth, was in foster care until 
17 months old when she was placed with us’.
Medication experiences were both positive: ‘The medi-
cation is an absolute God send. Without it our lives would 
be so stressful and I'm sure X wouldn’t be able to attend 
mainstream school’; and negative ‘can’t take any due 
to bad reaction on her stomach, tried 5 different ones’. 
Sleep problems were commonly mentioned: ‘Last night 
was a good night’s sleep for my son and he slept till after 
6. This is a rarity as he can be awake and hyperactive from 
2am.’. Many felt that ADHD is mis- understood and that 
the voices of families with ADHD not heard.
DISCUSSION
The number of families reporting that their children 
had codiagnoses suggest that in this regard, this conven-
ience sample are broadly representative of the ADHD 
population, where co- diagnoses are estimated to occur in 
40%–65%.30 31
This survey reports high levels of health need and use 
of public resources. The majority of those surveyed used 
mainstream treatments such as pharmaceutical medica-
tions, behaviour management classes and psychological 
therapies. Seven per cent of families were involved with 
social workers; 6% of children had been excluded from 
school and 5% were currently, or had been involved with 
the police. Additionally, 45% of families had used non- 
mainstream treatments.
The most commonly used non- mainstream treatments 
were homoeopathy and nutrition. The role of nutrition 
is increasingly acknowledged in the aetiology, impact on, 
and treatment of, ADHD. Consideration of nutrition is 
now moving towards the mainstream, as exemplified by 
its recent inclusion in NICE guidelines. More surprising 
is the high use of homoeopathy. It is unclear whether 
use refers to over the counter homeopathic medicines 
such as Arnica for bruising, or Chamomilla for teething, 
or visits to a homeopath (available via the NHS in some 
parts of the UK), or both.
Sample sizes of surveys conducted in other countries 
range from 73 to 822. Ours was 175. At 31%, our non- 
mainstream treatment use is slightly less than median 
usage found in other surveys (range 12%–71%) 
(table 1). Lower estimates are thought to be the result 
of narrower definitions of such treatments,19 32 however, 
our inclusion of an open- ended question theoreti-
cally allowed for broad definition of non- mainstream 
treatments, and indeed included a diverse array. 
Reported use appears to vary by country, with higher 
use reported in Australia (range 64%–71%) and lower 
use in the USA (range 12%–54%). Surveys agree that 
treatments are predominantly used alongside pharma-
ceutical medications (table 1).
The results of our survey broadly concur with those 
from other surveys. Although other surveys varied in 
the non- mainstream treatments they asked about, they 
commonly asked about dietary interventions (8/10), 
with some asking generally, and some specifically about 
supplements and dietary changes. Four surveys asked 
about herbs, homoeopathy or chiropractic/osteop-
athy; and three about acupuncture or yoga. According 
to the 10 surveys, the most popular treatments were 
supplements, dietary changes, acupuncture, homoe-
opathy, massage, craniosacral therapy, music therapy, 
equine therapy, secretin and chelation.
Popular treatments according to our survey were 
homoeopathy, nutrition (particularly supplementary 
fish oils), massage, osteopathy, aromatherapy, a variety of 
relaxation approaches, acupuncture and hypnotherapy. 
However, none in our survey reported using herbs. 
Unique to our survey was reported use of Cannabidiol 
oil, Epsom salts, metamorphic technique, reflexology, 
crystals and Bach flower remedies.
A limitation of our survey is the mixture of questions 
specifying a particular intervention (eg, have you done a 
parenting class/seen a psychologist/used homoeopathy) 
and more open questions (eg, what else have you done 
to help your child). There are advantages and disadvan-
tages of each question type: the use of an open- ended 
question allowed the broad spectrum of treatments being 
used to be represented; however, it is likely that some 
utilised treatments were omitted which might have been 
remembered had a prompt list been provided.
Most interventions being used are under researched 
and the evidence produced low quality due to: poor 
internal validity (lack of blinded assessment, and small 
population sizes); poor external validity (lack of trials 
in representative populations and lack of measurement 
of long- term outcomes); and poor ecological validity 
(tested interventions do not represent core aspects of the 
therapy). In 2000, it was identified as a public health issue 
in the UK that we do not have adequate knowledge of 
the putative benefits of non- mainstream treatments.33 We 
still have little information and just 0.0085% of research 
funding is allocated to testing Complementary and Alter-
native Medicine interventions in the UK.34
Of the treatments used, elements of a nutritional 
approach are the most researched, particularly the ‘few 
foods diet’, artificial food colour elimination, fatty acid 
supplementation, single and multiple nutrients. Effect 
sizes are generally small. Researchers concur that the few 
foods diet may offer opportunities, but further large- scale, 
high- quality studies are needed.35 It is unlikely that single 
nutrient or dietary interventions impact the complex 
array of biochemical pathways that may be aberrant in 
ADHD. Furthermore administration of one nutrient 
or approach may cause an imbalance in another.7 The 
pilot RCT conducted in our cohort tested the effective-
ness of offering a total nutritional approach combining 
supplementation, elimination, and healthy diet advice by 
a nutritional therapist.26 A medium effect size was found, 
and the pragmatic trial design used may address some of 
these issues.
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Homoeopathy is the next most researched treatment. 
Three RCTs testing the efficacy of individually tailored 
homoeopathic medicines,36–38 and one testing the effi-
cacy of a generic homeopathic product,39 were synthe-
sised in a Cochrane review40 which overall found little 
evidence of efficacy and recommended development of 
optimal treatment protocols. Subsequently, two further 
RCTs testing the effectiveness of treatment by homoeo-
paths,26 41 and one testing the efficacy of a generic 
homeopathic product,42 have been conducted.
Families used their experience of participating in an 
observational cohort to describe a broad variety of resources 
and treatments they use to manage the condition over and 
above NHS recommended treatments. This is a conve-
nience sample of participants in the UK who consented to 
recruit to a cohort, and it may be that dissatisfaction with 
conventional care drew them towards participation. Never-
theless, results from our survey do not deviate substantially 
from the results from population and clinical samples.
CONCLUSION
Development of robust evidence of the putative effective-
ness of the non- mainstream treatments being used should 
be a priority given that they are being used by carers; paedi-
atric doctors are increasingly turning to more natural treat-
ments; long- term negative outcomes of those with ADHD 
are not being affected; and currently recommended treat-
ments are palliative and associated with common side 
effects. Surveying carers is a useful means of identifying 
which treatments are being used and should subsequently 
be tested.
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